Skip to main content

Inside the Innovation: Pharmaceutical Development and Manufacturing Leaders Share Experiences

By: 3BL Media

SOURCE: Gilead Sciences

DESCRIPTION:

What goes into making innovative new medicines? In the second installment of our “Inside the Innovation” series, Gilead’s Ken Kent and Monica Tijerina discuss our patient-focused approach to developing medicines and the importance of including diverse voices throughout the process.

Originally published by Gilead Sciences

Tweet me: .@GileadSciences Ken Kent and Monica Tijerina discuss a patient-focused approach to developing medicines and the importance of including diverse voices throughout the process: https://bit.ly/3sbiMrx

KEYWORDS: NYSE: GILD, Gilead Sciences

Recent Quotes

View More
Symbol Price Change (%)
AMZN  205.38
-1.58 (-0.76%)
AAPL  276.33
+2.65 (0.97%)
AMD  213.40
-0.17 (-0.08%)
BAC  55.25
-0.14 (-0.25%)
GOOG  315.20
-3.43 (-1.08%)
META  667.12
-3.60 (-0.54%)
MSFT  405.81
-7.46 (-1.81%)
NVDA  190.36
+1.82 (0.97%)
ORCL  155.93
-3.96 (-2.48%)
TSLA  425.66
+0.45 (0.11%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.